Speroff L - Search Results

1

Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.

Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L. Kaunitz AM, et al. Among authors: speroff l. Contraception. 2009 Jul;80(1):7-17. doi: 10.1016/j.contraception.2009.02.005. Epub 2009 Mar 27. Contraception. 2009. PMID: 19501210 Clinical Trial.

2

Costs and net health effects of contraceptive methods.

Sonnenberg FA, Burkman RT, Hagerty CG, Speroff L, Speroff T. Sonnenberg FA, et al. Among authors: speroff t, speroff l. Contraception. 2004 Jun;69(6):447-59. doi: 10.1016/j.contraception.2004.03.008. Contraception. 2004. PMID: 15157789

3

Performance of the TCu380A and Cu-Fix IUDs in an international randomized trail.

Rosenberg MJ, Foldesy R, Mishell DR Jr, Speroff L, Waugh MS, Burkman R. Rosenberg MJ, et al. Among authors: speroff l. Contraception. 1996 Apr;53(4):197-203. doi: 10.1016/0010-7824(96)00036-4. Contraception. 1996. PMID: 8706436 Clinical Trial.

4

Contraception in the later reproductive years: a valid aspect of preventive health care.

Speroff L, Sulak PJ. Speroff L, et al. Dialogues Contracept. 1995 Winter;4(5):1-4. Dialogues Contracept. 1995. PMID: 12288679

5

Mircette: a novel oral contraceptive. Introduction.

Speroff L. Speroff L. Am J Obstet Gynecol. 1998 Jul;179(1):S1. Am J Obstet Gynecol. 1998. PMID: 9704811 No abstract available.

6

Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.

Speroff L, Haney AF, Gilbert RD, Ellman H; Estradiol Acetate Investigator Group. Speroff L, et al. Menopause. 2006 May-Jun;13(3):442-50. doi: 10.1097/01.gme.0000182802.06762.b2. Menopause. 2006. PMID: 16735941 Clinical Trial.

7

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.

Rowan JP, Simon JA, Speroff L, Ellman H. Rowan JP, et al. Among authors: speroff l. Clin Ther. 2006 Jun;28(6):921-32. doi: 10.1016/j.clinthera.2006.06.013. Clin Ther. 2006. PMID: 16860174

8

Low-dose hormone therapy in postmenopausal women in China.

Zang H, Shi H, Speroff L. Zang H, et al. Among authors: speroff l. Climacteric. 2010 Dec;13(6):544-52. doi: 10.3109/13697130903395201. Epub 2009 Nov 25. Climacteric. 2010. PMID: 19938946

9

The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

Speroff L, Rowan J, Symons J, Genant H, Wilborn W. Speroff L, et al. JAMA. 1996 Nov 6;276(17):1397-403. JAMA. 1996. PMID: 8892714 Clinical Trial.

10

Transdermal hormone therapy and the risk of stroke and venous thrombosis.

Speroff L. Speroff L. Climacteric. 2010 Oct;13(5):429-32. doi: 10.3109/13697137.2010.507111. Climacteric. 2010. PMID: 20670199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results